Effects of tobacco constituents and psychological stress on the beta-adrenergic regulation of non-small cell lung cancer and pancreatic cancer: Implications for intervention

Cancer Biomarkers

Volumn 13, Issue 3, 2013, Pages 133-144

  Schuller, Hildegard M ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

beta adrenergic signaling; cancer intervention; NSCLC; psychological stress; tobacco constituents

Indexed keywords

4 AMINOBUTYRIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLIC AMP; NEUROTRANSMITTER; NICOTINE; NICOTINIC RECEPTOR; PROTEIN P53;

ADRENERGIC SYSTEM; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DESENSITIZATION; EPITHELIUM CELL; GENE MUTATION; HUMAN; LUNG NON SMALL CELL CANCER; MENTAL STRESS; METABOLITE; NONHUMAN; ONCOGENE K RAS; PANCREAS CANCER; PRIORITY JOURNAL; PROTO ONCOGENE; SENSITIZATION; SIGNAL TRANSDUCTION; SOCIAL STRESS; TOBACCO; TUMOR SUPPRESSOR GENE;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; PANCREATIC NEOPLASMS; RECEPTORS, ADRENERGIC, BETA; STRESS, PSYCHOLOGICAL; TOBACCO USE;

EID: 84881444195     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-130323     Document Type: Article

References (81)

1. P.A. Bunn, Jr., N. Thatcher, Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Conclusion, Oncologist 13 Suppl 1 (2008) 37-46.
2. H.A.Wakelee, E.T. Chang, S.L. Gomez, T.H. Keegan, D. Feskanich, C.A. Clarke, L. Holmberg, L.C. Yong, L.N. Kolonel, M.K. Gould, D.W. West, Lung cancer incidence in never smokers, J Clin Oncol 25 (2007) 472-478. (Pubitemid 350002951)
3. P. Boffetta, B. Jarvholm, P. Brennan, O. Nyren, Incidence of lung cancer in a large cohort of non-smoking men from Sweden, Int J Cancer 94 (2001) 591-593.
4. S.S. Devesa, F. Bray, A.P. Vizcaino, D.M. Parkin, International lung cancer trends by histologic type: male: Female differences diminishing and adenocarcinoma rates rising, Int J Cancer 117 (2005) 294-299. (Pubitemid 41379403)
5. Y. Toyoda, T. Nakayama, A. Ioka, H. Tsukuma, Trends in lung cancer incidence by histological type in Osaka, Japan, Jpn J Clin Oncol 38 (2008) 534-539.
6. C.A. Haiman, D.O. Stram, L.R. Wilkens, M.C. Pike, L.N. Kolonel, B.E. Henderson, L. Le Marchand, Ethnic and racial differences in the smoking-related risk of lung cancer, N Engl J Med 354 (2006) 333-342. (Pubitemid 43145058)
7. T. Yano, A. Haro, Y. Shikada, R. Maruyama, Y. Maehara, Non-small cell lung cancer in never smokers as a representative 'non-smoking-associated lung cancer': Epidemiology and clinical features, Int J Clin Oncol 16 (2011) 287-293.
8. A.B. Lowenfels, P. Maisonneuve, Risk factors for pancreatic cancer, J Cell Biochem 95 (2005) 649-656. (Pubitemid 41420153)
9. K. Almhanna, P.A. Philip, Defining new paradigms for the treatment of pancreatic cancer, Curr Treat Options Oncol 12 (2011) 111-125.
10. A. Arfe,M.Malvezzi, P. Bertuccio, A. Decarli, C. La Vecchia, E. Negri, Cancer mortality trend analysis in Italy, 1970-2007, Eur J Cancer Prev 20 (2011) 364-374.
11. V. Jooste, L. Remontet, M. Colonna, A. Belot, G. Launoy, F. Binder, J. Faivre, A.M. Bouvier, Trends in the incidence of digestive cancers in France between 1980 and 2005 and projections for the year 2010, Eur J Cancer Prev 20 (2011) 375-380.
12. J.D. Robinson, P.M. Cinciripini, The effects of stress and smoking on catecholaminergic and cardiovascular response, Behav Med 32 (2006) 13-18.
13. H.M. Schuller, B. Cole, Regulation of cell proliferation by beta-adrenergic receptors in a human lung adenocarcinoma cell line, Carcinogenesis 10 (1989) 1753-1755. (Pubitemid 19222282)
14. P.G. Park, J. Merryman, M. Orloff, H.M. Schuller, Betaadrenergic mitogenic signal transduction in peripheral lung adenocarcinoma: implications for individuals with preexisting chronic lung disease, Cancer Res 55 (1995) 3504-3508.
15. D.L. Weddle, P. Tithoff, M. Williams, H.M. Schuller, Betaadrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas, Carcinogenesis 22 (2001) 473-479. (Pubitemid 32203828)
16. H.A.N. Al-Wadei, H.K. Plummer, 3rd, M.F. Ullah, B. Unger, J. Brody, H.M. Schuller, Social stress promotes and γ- aminobutyric acid inhibits tumor growth in mouse models of non small cell lung cancer, Cancer Prevent Res 5 (2012) 189- 196.
17. H.M. Schuller, H.A. Al-Wadei, M.F. Ullah, H.K. Plummer, 3rd, Regulation of pancreatic cancer by neuropsychological stress responses: a novel target for intervention, Carcinogenesis 33 (2012) 191-196.
18. S. Di Angelantonio, C. Matteoni, E. Fabbretti, A. Nistri, Molecular biology and electrophysiology of neuronal nicotinic receptors of rat chromaffin cells, Eur J Neurosci 17 (2003) 2313-2322. (Pubitemid 36793740)
19. H.A. Al-Wadei, M.H. Al-Wadei, T. Masi, H.M. Schuller, Chronic exposure to estrogen and the tobacco carcinogen NNK cooperatively modulates nicotinic receptors in small airway epithelial cells, Lung Cancer 69 (2010) 33-39.
20. M.H. Al-Wadei, H.A. Al-Wadei, H.M. Schuller, Pancreatic Cancer Cells and Normal Pancreatic Duct Epithelial Cells Express an Autocrine Catecholamine Loop that Is Activated by Nicotinic Acetylcholine Receptors alpha3, alpha5, and alpha7, Mol Cancer Res 10 (2012) 239-249.
21. B. Prokopczyk, D. Hoffmann, M. Bologna, A.J. Cunningham, N. Trushin, S. Akerkar, T. Boyiri, S. Amin, D. Desai, S. Colosimo, B. Pittman, G. Leder, M. Ramadani, D. Henne- Bruns, H.G. Beger, K. El-Bayoumy, Identification of tobaccoderived compounds in human pancreatic juice, Chem Res Toxicol 15 (2002) 677-685. (Pubitemid 34535123)
22. H.M. Schuller, P.K. Tithof, M. Williams, H. Plummer, 3rd, The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via betaadrenergic receptor-mediated release of arachidonic acid, Cancer Res 59 (1999) 4510-4515. (Pubitemid 29428948)
23. H.M. Schuller, Mechanisms of smoking-related lung and pancreatic adenocarcinoma development, Nat Rev Cancer 2 (2002) 455-463. (Pubitemid 37328942)
24. H.M. Schuller, H.K. Plummer, 3rd, P.N. Bochsler, P. Dudric, J.L. Bell, R.E. Harris, Co-expression of beta-adrenergic receptors and cyclooxygenase-2 in pulmonary adenocarcinoma, Int J Oncol 19 (2001) 445-449.
25. E. Laag, M. Majidi, M. Cekanova, T. Masi, T. Takahashi, H.M. Schuller, NNK activates ERK1/2 and CREB/ATF-1 via beta-1-AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cells, Int J Cancer 119 (2006) 1547-1552. (Pubitemid 44258759)
26. M. Majidi, H.A. Al-Wadei, T. Takahashi, H.M. Schuller, Nongenomic beta estrogen receptors enhance beta1 adrenergic signaling induced by the nicotine-derived carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human small airway epithelial cells, Cancer Res 67 (2007) 6863- 6871. (Pubitemid 47105533)
27. M.D. Askari, M.S. Tsao, H.M. Schuller, The tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone stimulates proliferation of immortalized human pancreatic duct epithelia through beta-adrenergic transactivation of EGF receptors, J Cancer Res Clin Oncol 131 (2005) 639-648. (Pubitemid 41502206)
28. C. Pavoine, S. Magne, A. Sauvadet, F. Pecker, Evidence for a beta2-adrenergic/arachidonic acid pathway in ventricular cardiomyocytes. Regulation by the beta1-adrenergic/camp pathway, J Biol Chem 274 (1999) 628-637.
29. E.F. LaBelle, E. Polyak, Norepinephrine stimulates arachidonic acid release from vascular smooth muscle via activation of cPLA2, Am J Physiol 274 (1998) C1129-1137.
30. H.M. Schuller, B. Porter, A. Riechert, Beta-adrenergic modulation of NNK-induced lung carcinogenesis in hamsters, J Cancer Res Clin Oncol 126 (2000) 624-630.
31. H.A. Al-Wadei, M.H. Al-Wadei, H.M. Schuller, Prevention of pancreatic cancer by the beta-blocker propranolol, Anticancer Drugs 20 (2009) 477-482.
32. H.M. Schuller, L. Zhang, D.L. Weddle, A. Castonguay, K. Walker, M.S. Miller, The cyclooxygenase inhibitor ibuprofen and the FLAP inhibitor MK886 inhibit pancreatic carcinogen esis induced in hamsters by transplacental exposure to ethanol and the tobacco carcinogen NNK, J Cancer Res Clin Oncol 128 (2002) 525-532. (Pubitemid 35244927)
33. H.M. Schuller, M. Orloff, Tobacco-specific carcinogenic nitrosamines. Ligands for nicotinic acetylcholine receptors in human lung cancer cells, Biochem Pharmacol 55 (1998) 1377-1384. (Pubitemid 28298517)
34. J. Arredondo, A.I. Chernyavsky, S.A. Grando, The nicotinic receptor antagonists abolish pathobiologic effects of tobaccoderived nitrosamines on BEP2D cells, J Cancer Res Clin Oncol 132 (2006) 653-663. (Pubitemid 44310331)
35. J. Arredondo, A.I. Chernyavsky, S.A. Grando, Nicotinic receptors mediate tumorigenic action of tobacco-derived nitrosamines on immortalized oral epithelial cells, Cancer Biol Ther 5 (2006) 511-517. (Pubitemid 43765286)
36. H.A. Al-Wadei, H.K. Plummer, 3rd, H.M. Schuller, Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter gamma-aminobutyric acid, Carcinogenesis 30 (2009) 506-511.
37. H.P. Wong, L. Yu, E.K. Lam, E.K. Tai, W.K. Wu, C.H. Cho, Nicotine promotes cell proliferation via alpha7-nicotinic acetylcholine receptor and catecholamine-synthesizing enzymes- mediated pathway in human colon adenocarcinoma HT- 29 cells, Toxicol Appl Pharmacol 221 (2007) 261-267. (Pubitemid 46855813)
38. V.Y. Shin, W.K. Wu, K.M. Chu, M.W. Koo, H.P. Wong, E.K. Lam, E.K. Tai, C.H. Cho, Functional role of beta-adrenergic receptors in the mitogenic action of nicotine on gastric cancer cells, Toxicol Sci 96 (2007) 21-29. (Pubitemid 46323205)
39. M.H. Al-Wadei, H.A. Al-Wadei, H.M. Schuller, Effects of chronic nicotine on the autocrine regulation of pancreatic cancer cells and pancreatic duct epithelial cells by stimulatory and inhibitory neurotransmitters, Carcinogenesis.
40. R.J. Lefkowitz, The superfamily of heptahelical receptors, Nat Cell Biol 2 (2000) E133-136.
41. A. Markou, Review. Neurobiology of nicotine dependence, Philos Trans R Soc Lond B Biol Sci 363 (2008) 3159-3168.
42. H.M. Schuller, Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? Nat Rev Cancer 9 (2009) 195-205.
43. H.M. Schuller, H.A. Al-Wadei, M. Majidi, Gammaaminobutyric acid, a potential tumor suppressor for small airway- derived lung adenocarcinoma, Carcinogenesis 29 (2008) 1979-1985.
44. H.M. Schuller, H.A. Al-Wadei, M. Majidi, GABA B receptor is a novel drug target for pancreatic cancer, Cancer 112 (2008) 767-778. (Pubitemid 351240570)
45. H. Bernert, H.K. Plummer III, H.M. Schuller, Chronic nicotine and NNK exposure causes promoter hypermethylation of GAD2 in human pancreatic duct epithelial cells., AACR 102nd Annual Meeting, vol. 52, Orlando, FL, USA, 2011, p. 3816.
46. H.A. Al-Wadei, M.H. Al-Wadei, M.F. Ullah, H.M. Schuller, Gamma-amino butyric acid inhibits the nicotine-imposed stimulatory challenge in xenograft models of non-small cell lung carcinoma, Curr Cancer Drug Targets 12 (2012) 97-106.
47. S.S. Hecht, DNA adduct formation from tobacco-specific Nnitrosamines, Mutat Res 424 (1999) 127-142. (Pubitemid 29101614)
48. M. Sato, M.B. Vaughan, L. Girard, M. Peyton, W. Lee, D.S. Shames, R.D. Ramirez, N. Sunaga, A.F. Gazdar, J.W. Shay, J.D. Minna, Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells, Cancer Res 66 (2006) 2116-2128.
49. R. Liu, B. Ramani, D. Soto, V. De Arcangelis, Y. Xiang, Agonist dose-dependent phosphorylation by protein kinase A and G protein-coupled receptor kinase regulates beta2 adrenoceptor coupling to G(i) proteins in cardiomyocytes, J Biol Chem 284 (2009) 32279-32287.
50. V. Sterlemann, K. Ganea, C. Liebl, D. Harbich, S. Alam, F. Holsboer, M.B. Muller, M.V. Schmidt, Long-term behavioral and neuroendocrine alterations following chronic social stress inmice: implications for stress-related disorders, Horm Behav 53 (2008) 386-394.
51. B.S. McEwen, The neurobiology of stress: from serendipity to clinical relevance, Brain Res 886 (2000) 172-189.
52. H.A. Al-Wadei, M.H. Al.-wadei, M.F. Ullah, H.M. Schuller, Celecoxib and GABA cooperatively prevent the progression of pancreatic cancer om vitro and in xenograft models of stress-free and stress-exposed mice., Plos One (in press) (2012).
53. X.Y. Huang, H.C. Wang, Z. Yuan, J. Huang, Q. Zheng, Norepinephrine stimulates pancreatic cancer cell proliferation, migration and invasion via beta-adrenergic receptor-dependent activation of P38/MAPK pathway, Hepatogastroenterology 59 (2012) 889-893.
54. T. Shan, Q. Ma, D. Zhang, K. Guo, H. Liu, F. Wang, E. Wu, beta2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction, Eur J Pharmacol 665 (2011) 1-7.
55. M. Hamer, Y. Chida, G.J. Molloy, Psychological distress and cancer mortality, J Psychosom Res 66 (2009) 255-258.
56. J. Zabora, K. BrintzenhofeSzoc, B. Curbow, C. Hooker, S. Piantadosi, The prevalence of psychological distress by cancer site, Psychooncology 10 (2001) 19-28. (Pubitemid 32106774)
57. H.K. Plummer, 3rd, M.S. Dhar, M. Cekanova, H.M. Schuller, Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines, BMC Cancer 5 (2005) 104.
58. S.H. Shafer, S.H. Phelps, C.L. Williams, Reduced DNA synthesis and cell viability in small cell lung carcinoma by treatment with cyclic AMP phosphodiesterase inhibitors, Biochem Pharmacol 56 (1998) 1229-1236. (Pubitemid 28511247)
59. A. Aleksijevic, C. Lugnier, C. Giron, S. Mayer, J.C. Stoclet, J.M. Lang, Cyclic AMP and cyclic GMP phosphodiesterase activities in Hodgkin's disease lymphocytes, Int J Immunopharmacol 9 (1987) 525-531. (Pubitemid 17101937)
60. H.M. Schuller, B. Porter, A. Riechert, K. Walker, R. Schmoyer, Neuroendocrine lung carcinogenesis in hamsters is inhibited by green tea or theophylline while the development of adenocarcinomas is promoted: implications for chemoprevention in smokers, Lung Cancer 45 (2004) 11-18. (Pubitemid 38757827)
61. H.A. Al-Wadei, H.M. Schuller, Non-genomic inhibitory signaling of beta-carotene in squamous cell carcinoma of the lungs, Int J Oncol 34 (2009) 1093-1098.
62. F. Song, A.A. Qureshi, J. Han, Increased caffeine intake is associated with reduced risk of Basal cell carcinoma of the skin, Cancer Res 72 (2012) 3282-3289.
63. Y. Goldfarb, L. Sorski, M. Benish, B. Levi, R. Melamed, S. Ben-Eliyahu, Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses, Ann Surg 253 (2011) 798-810.
64. B.R. Celli, Chronic obstructive pulmonary disease and lung cancer: common pathogenesis, shared clinical challenges, Proc Am Thorac Soc 9 (2012) 74-79.
65. T. Maki, K. Kontula, M. Harkonen, The beta-adrenergic system in man: physiological and pathophysiological response. Regulation of receptor density and functioning, Scand J Clin Lab Invest Suppl 201 (1990) 25-43. (Pubitemid 20271059)
66. C. Rosendorff, Beta-blocking agents with vasodilator activity, J Hypertens Suppl 11 (1993) S37-40. (Pubitemid 23226737)
67. P. Lund-Johansen, P. Omvik, Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: a comparison between alpha blockers and different types of beta blockers with and without vasodilating effect, Cardiovasc Drugs Ther 5 (1991) 605-615.
68. A. Cesario, P. Russo, C. Nastrucci, P. Granone, Is alpha7- nAChR a possible target for lung cancer and malignant pleural mesothelioma treatment?, Curr Drug Targets 13 (2012) 688- 694.
69. C.I. Amos, I.P. Gorlov, Q. Dong, X. Wu, H. Zhang, E.Y. Lu, P. Scheet, A.J. Greisinger, G.B. Mills, M.R. Spitz, Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: A case-control study, J Natl Cancer Inst 102 (2010) 1199-1205.
70. J. Joseph, B. Niggemann, K.S. Zaenker, F. Entschladen, The neurotransmitter gamma-aminobutyric acid is an inhibitory regulator for the migration of SW 480 colon carcinoma cells, Cancer Res 62 (2002) 6467-6469. (Pubitemid 35364108)
71. T.L.t. Drell, J. Joseph, K. Lang, B. Niggemann, K.S. Zaenker, F. Entschladen, Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells, Breast Cancer Res Treat 80 (2003) 63-70. (Pubitemid 36851285)
72. A. Takehara, M. Hosokawa, H. Eguchi, H. Ohigashi, O. Ishikawa, Y. Nakamura, H. Nakagawa, Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit, Cancer Res 67 (2007) 9704-9712. (Pubitemid 47621217)
73. M.H. Antoni, S.K. Lutgendorf, S.W. Cole, F.S. Dhabhar, S.E. Sephton, P.G. McDonald, M. Stefanek, A.K. Sood, The influence of bio-behavioural factors on tumour biology: pathways and mechanisms, Nat Rev Cancer 6 (2006) 240-248. (Pubitemid 43292567)
74. K. Masur, B. Niggemann, K.S. Zanker, F. Entschladen, Norepinephrine- induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers, Cancer Res 61 (2001) 2866-2869. (Pubitemid 32691927)
75. K. Lang, T.L.t. Drell, A. Lindecke, B. Niggemann, C. Kaltschmidt, K.S. Zaenker, F. Entschladen, Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs, Int J Cancer 112 (2004) 231-238. (Pubitemid 39244363)
76. D. Palm, K. Lang, B. Niggemann, T.L.t. Drell, K. Masur, K.S. Zaenker, F. Entschladen, The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers, Int J Cancer 118 (2006) 2744-2749. (Pubitemid 43673352)
77. D.G. Powe, M.J. Voss, K.S. Zanker, H.O. Habashy, A.R. Green, I.O. Ellis, F. Entschladen, Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival, Oncotarget 1 (2010) 628-638.
78. A. Melhem-Bertrandt, M. Chavez-Macgregor, X. Lei, E.N. Brown, R.T. Lee, F. Meric-Bernstam, A.K. Sood, S.D. Conzen, G.N. Hortobagyi, A.M. Gonzalez-Angulo, Betablocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer, J Clin Oncol 29 (2011) 2645-2652.
79. A.K. Sood, R. Bhatty, A.A. Kamat, C.N. Landen, L. Han, P.H. Thaker, Y. Li, D.M. Gershenson, S. Lutgendorf, S.W. Cole, Stress hormone-mediated invasion of ovarian cancer cells, Clin Cancer Res 12 (2006) 369-375. (Pubitemid 43166123)
80. M.R. Hara, J.J. Kovacs, E.J.Whalen, S. Rajagopal, R.T. Strachan, W. Grant, A.J. Towers, B. Williams, C.M. Lam, K. Xiao, S.K. Shenoy, S.G. Gregory, S. Ahn, D.R. Duckett, R.J. Lefkowitz, A stress response pathway regulates DNA damage through beta2-adrenoreceptors and beta-arrestin-1, Nature 477 349-353.
81. B.T. Gurfein, A.W. Stamm, P. Bacchetti, M.F. Dallman, N.A. Nadkarni, J.M. Milush, C. Touma, R. Palme, C.P. Di Borgo, G. Fromentin, R. Lown-Hecht, J.P. Konsman, M. Acree, M. Premenko-Lanier, N. Darcel, F.M. Hecht, D.F. Nixon, The calm mouse: An animal model of stress reduction, Mol Med 18 (2012) 606-617.